Expanding Spectrum of Sodium Potassium Chloride Co-transporters in the Pathophysiology of Diseases

Author(s): Amteshwar Singh Jaggi, Aalamjeet Kaur, Anjana Bali, Nirmal Singh.

Journal Name: Current Neuropharmacology

Volume 13 , Issue 3 , 2015

Become EABM
Become Reviewer

Abstract:

Sodium potassium chloride co-transporter (NKCC) belongs to cation-dependent chloride co-transporter family, whose activation allows the entry of Na+, K+ and 2Cl- inside the cell. It acts in concert with K+ Cl- co-transporter (KCC), which extrudes K+ and Cl- ions from cell. NKCC1 is widely distributed throughout the body, while NKCC2 is exclusively present in kidney. Protein kinase A, protein kinase C, Ste20-related proline-alanine-rich kinase, oxidative stress responsive kinases, With No K=lysine kinase and protein phosphatase type 1 control the phosphorylation/dephosphorylation of key threonine residues of in regulatory domain of NKCC1. The selective inhibitors of NKCC1 including bumetanide and furosemide are conventionally employed as diuretics. However, recent studies have indicated that NKCC1 may be involved in the pathophysiology of anxiety, cerebral ischemia, epilepsy, neuropathic pain, fragile X syndrome, autism and schizophrenia. The inhibitors of NKCC1 are shown to produce anxiolytic effects; attenuate cerebral ischemia-induced neuronal injury; produce antiepileptic effects and attenuate neuropathic pain. In the early developing brain, GABAA activation primarily produces excitatory actions due to high NKCC1/KCC2 ratio. However, as the development progresses, the ratio of NKCC1/KCC2 ratio reverses and there is switch in the polarity of GABAA actions and latter acquires the inhibitory actions. The recapitulation of developmental-like state during pathological state may be associated with increase in the expression and functioning of NKCC1, which decreases the strength of inhibitory GABAergic neurotransmission. The present review describes the expanding role and mechanism of NKCC1 in the pathophysiology of different diseases.

Keywords: Anxiety, cerebral ischemia, neuropathic pain, sodium potassium chloride co-transporter.

Rights & PermissionsPrintExport Cite as


Article Details

VOLUME: 13
ISSUE: 3
Year: 2015
Page: [369 - 388]
Pages: 20
DOI: 10.2174/1570159X13666150205130359
Price: $58

Article Metrics

PDF: 29